| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±3.6% | -2.5% | over-priced |
| 07/29/2026 | ±3.1% | +0.5% | over-priced |
| 04/23/2026 | ±2.5% | -2.7% | under-priced |
| 02/12/2026 | ±5.9% | -8.8% | under-priced |
| 10/23/2025 | ±2.0% | +0.3% | over-priced |
| 07/29/2025 | ±1.9% | +7.8% | under-priced |
| 04/24/2025 | ±3.5% | +0.7% | over-priced |
| 02/14/2025 | ±3.0% | +0.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.52 | $11.5B | $443M |
| Q2 FY2026 | $0.69 | $11.2B | $204M |
| Q1 FY2026 | $1.07 | $10.5B | $318M |
| Q4 FY2025 | — | $11.6B | $416M |
CBRE (CBRE) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 3.0% on average — the market has been roughly fair on CBRE's earnings risk. Fundamentals into the print: EPS up 25.6% year-over-year, revenue up 12.3%. QuantLogix's live 5-factor engine currently reads CBRE as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →